Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated biochemistry analyzers and bio reagents; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; and glycated hemoglobin analyzer, blood lipid analyzer, POCT, microfluidic biochemical analyzer. The company also provides urine analyzers, urine sediment analyzers; PCR kit, antibody test kit, antigen and antibody test kit, and nucleic acid reagent for COVID-19. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.
Metrics to compare | 300439 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300439PeersSector | |
---|---|---|---|---|
P/E Ratio | 21.3x | 40.4x | −0.5x | |
PEG Ratio | −0.98 | −0.78 | 0.00 | |
Price/Book | 1.5x | 2.4x | 2.6x | |
Price / LTM Sales | 2.7x | 7.7x | 3.3x | |
Upside (Analyst Target) | - | 1.1% | 40.6% | |
Fair Value Upside | Unlock | 9.1% | 5.3% | Unlock |